NeuroMetrix Begin Period Cash Flow from 2010 to 2024
| NURO Stock | USD 4.25 0.10 2.41% |
Begin Period Cash Flow | First Reported 2004-03-31 | Previous Quarter 1.3 M | Current Value 1.6 M | Quarterly Volatility 6.3 M |
Check NeuroMetrix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NeuroMetrix's main balance sheet or income statement drivers, such as Depreciation And Amortization of 52.9 K, Interest Expense of 278 K or Total Revenue of 5.6 M, as well as many indicators such as Price To Sales Ratio of 0.6, Dividend Yield of 21.96 or PTB Ratio of 0.18. NeuroMetrix financial statements analysis is a perfect complement when working with NeuroMetrix Valuation or Volatility modules.
NeuroMetrix | Begin Period Cash Flow |
Latest NeuroMetrix's Begin Period Cash Flow Growth Pattern
Below is the plot of the Begin Period Cash Flow of NeuroMetrix over the last few years. It is the amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. NeuroMetrix's Begin Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NeuroMetrix's overall financial position and show how it may be relating to other accounts over time.
| Begin Period Cash Flow | 10 Years Trend |
|
Begin Period Cash Flow |
| Timeline |
NeuroMetrix Begin Period Cash Flow Regression Statistics
| Arithmetic Mean | 8,426,928 | |
| Geometric Mean | 7,124,287 | |
| Coefficient Of Variation | 64.94 | |
| Mean Deviation | 4,058,794 | |
| Median | 6,780,429 | |
| Standard Deviation | 5,472,209 | |
| Sample Variance | 29.9T | |
| Range | 19.4M | |
| R-Value | (0.20) | |
| Mean Square Error | 30.9T | |
| R-Squared | 0.04 | |
| Significance | 0.47 | |
| Slope | (245,883) | |
| Total Sum of Squares | 419.2T |
NeuroMetrix Begin Period Cash Flow History
About NeuroMetrix Financial Statements
NeuroMetrix investors utilize fundamental indicators, such as Begin Period Cash Flow, to predict how NeuroMetrix Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Begin Period Cash Flow | 4.3 M | 4.1 M |
Pair Trading with NeuroMetrix
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NeuroMetrix position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeuroMetrix will appreciate offsetting losses from the drop in the long position's value.Moving against NeuroMetrix Stock
The ability to find closely correlated positions to NeuroMetrix could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NeuroMetrix when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NeuroMetrix - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NeuroMetrix to buy it.
The correlation of NeuroMetrix is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NeuroMetrix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NeuroMetrix moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NeuroMetrix can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of NeuroMetrix Correlation against competitors. To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeuroMetrix. If investors know NeuroMetrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeuroMetrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.62) | Revenue Per Share 2.157 | Quarterly Revenue Growth (0.51) | Return On Assets (0.28) | Return On Equity (0.43) |
The market value of NeuroMetrix is measured differently than its book value, which is the value of NeuroMetrix that is recorded on the company's balance sheet. Investors also form their own opinion of NeuroMetrix's value that differs from its market value or its book value, called intrinsic value, which is NeuroMetrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeuroMetrix's market value can be influenced by many factors that don't directly affect NeuroMetrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeuroMetrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if NeuroMetrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeuroMetrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.